Why is Godavari Drugs falling/rising?

As of 02-Jul, Godavari Drugs Ltd is experiencing a decline in its stock price, currently at Rs 89.67, which represents a decrease of Rs 1.33 or 1.46%. The stock has been underperforming, having lost 4.34% over the last two days and showing a significant decline of 7.51% over the past month. Despite opening with a gain of 2.2% today and reaching an intraday high of Rs 93, it ultimately fell to a low of Rs 89. The stock is trading below all its moving averages, indicating a bearish trend. Additionally, while the company has an attractive valuation with a return on capital employed (ROCE) of 12.3%, it has faced challenges, including a 22.1% drop in profits over the past year and a high debt-to-EBITDA ratio of 3.15 times, which raises concerns about its long-term financial health. In the broader market context, Godavari Drugs has significantly underperformed compared to the Sensex, which has gained 0.79% over the past week while the stock has declined by 3.98%. This trend of underperformance is evident over various time frames, including a year-to-date drop of 18.00% against a 6.75% rise in the benchmark. The stock's recent struggles, coupled with negative financial results and a lack of strong long-term fundamentals, contribute to a bearish outlook, making it a strong sell in the current market environment.